Biglycan Alleviates Age-Related Muscle Atrophy and Hepatocellular Senescence
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178286 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Da Som Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrine and Kidney Disease Research, Department of Chronic Disease Convergence Research, National Institute of Health, Cheongju 28159, …. Hauptthemen laut MEDLINE: Biglycan, Muscular Atrophy, Cellular Senescence, Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea National Institute of Health.
Abstract (Originalsprache)
Myokines are secreted by muscle and play crucial roles in muscle repair and regeneration and also impact diverse physiological effects through crosstalk with other metabolic organs. However, aging is associated with a progressive decline in muscle mass, which in turn leads to reduced myokine secretion. This decline may contribute to the development of sarcopenia, leading to an increased risk of metabolic disorders such as type 2 diabetes. Accordingly, interest in identifying novel myokines and elucidating their biological functions is increasing. In this study, we explored the function of biglycan (BGN), a novel myokine, in aging-related metabolic tissues. BGN levels decreased in the muscle tissue and plasma of older adults and aged mice, whereas exercise intervention restored BGN expression in aged mice. BGN counteracted the expression of atrophy-related genes involved in muscle degradation and mitigated muscle mass loss by regulating AKT/mTOR signaling pathway. Notably, BGN decreased the expression of the senescence marker p21 and senescence-associated secretory phenotype (SASP)-related genes in hepatocytes. Additionally, BGN attenuated senescence-induced lipid accumulation and ROS generation. Our results suggest that BGN has beneficial effects against muscle atrophy and hepatocellular senescence, indicating its potential as a protective factor for age-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrine and Kidney Disease Research, Department of Chronic Disease Convergence Research, National Institute of Health, Cheongju 28159, Republic of Korea.
ORCID-Profile: Da Som Lee, Joo Hyun Lim, Yoo Jeong Lee
Förderung
- Korea National Institute of Health
Zitieren
APA
Lee, D. S., Lim, J. H., & Lee, Y. J. (2025). Biglycan Alleviates Age-Related Muscle Atrophy and Hepatocellular Senescence. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178286
Vancouver
Lee DS, Lim JH, Lee YJ. Biglycan Alleviates Age-Related Muscle Atrophy and Hepatocellular Senescence. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178286
BibTeX
@article{Lee2025,
author = {Lee, Da Som and Lim, Joo Hyun and Lee, Yoo Jeong},
title = {Biglycan Alleviates Age-Related Muscle Atrophy and Hepatocellular Senescence},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178286}
}
EUVIMED